Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
4.610
+0.410 (9.76%)
At close: Jul 25, 2025, 4:00 PM
4.629
+0.019 (0.42%)
After-hours: Jul 25, 2025, 7:55 PM EDT

Generation Bio Co. Revenue

Generation Bio Co. had revenue of $8.72M in the quarter ending March 31, 2025, with 114.91% growth. This brings the company's revenue in the last twelve months to $24.56M, up 146.47% year-over-year. In the year 2024, Generation Bio Co. had annual revenue of $19.89M with 236.92% growth.

Revenue (ttm)
$24.56M
Revenue Growth
+146.47%
P/S Ratio
1.25
Revenue / Employee
$213,530
Employees
115
Market Cap
30.90M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202419.89M13.99M236.92%
Dec 31, 20235.90M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings